Antinuclear antibodies in multiple sclerosis;Los anticuerpos antinucleares en la esclerosis multiple

Neurologia

Volumn 12, Issue 6, 1997, Pages 245-248

  Antiguedad A ^a,b   Ruiz, J ^a   Mendibe, M M ^a   Zarranz, J J ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

Antinuclear antibodies; Multiple sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PREVALENCE;

ADULT; ANTIBODIES, ANTINUCLEAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 0030837796     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Seyfert S, Klapps P, Meisel C, Fischer T, Junghan U. Multiple sclerosis and other immunologie diseases. Acta Neurol Scand 1990; 81: 37-42.
2. De Keyser J. Autoimmunity in multiple sclerosis. Neurology 1988; 38: 371-374.
3. Barned S, Goodman AD, Mattson DH. Frequency of antinuclear antibodies in multiple sclerosis. Neurology 1995; 45: 384-385.
4. Tan EM, Chan EKL, Sullivan KF, Rubin RL. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 1988; 47: 121-141.
5. Richardson B, Epstein WV. Utility of the fluorescent antinuclear antibody test in a single patient. Ann Intern Med 1981; 95: 333-338.
6. Michielsens B, Walravens M, Vermylen J, Carton H. Diagnostic significance of antinuclear antibodies in neurologic patients. Acta Neurol Scand 1991; 84: 102-106.
7. Matthews WB. Differential diagnosis. En: Matthews WB, editor. McAlpine's multiple sclerosis (2.a ed.). Edimburgo, Londres, Melbourne, Nueva York: Churchill Livingstone, 1991; 165-188.
8. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis-Rheum 1982; 25: 1.271-1.277.
10. Vitali C, Bombardieri S, Montsopoulos HM, Balestrieri G, Bencivilli W, Bernstein R et al. Preliminary criteria for the classification of Sjögren's syndrome. Arthritis Rheum 1993; 36: 340-347.
11. Alarcón-Segovia D, Cardiel MM. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989; 16: 328-334.
12. Compston DAS. Immunological aspects. En: Matthews WB, editor. McAlpine's multiple sclerosis (2.a ed.). Edimburgo, Londres, Melbourne, Nueva York: Churchill Livingstone, 1991; 321-339.
13. Dore-Duffy P, Donaldson JO, Rothman BL, Zurier RB. Antinuclear antibodies in multiple sclerosis. Arch Neurol 1982; 39: 504-506.
14. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale. Neurology 1983; 33: 1.444-1.452.